Logo

Newsletter
March 2022

 
 

Welcome to our March Newsletter for all the latest TREAT-NMD news and events. 


Articles in the edition...

  • TREAT-NMD conference programme released 
  • Launch of the Daniel Ferguson Foundation 
  • TREAT-NMD Education events success
 
 
 
‌
Uncategorized Treat NMD 223

TREAT-NMD Education Event Success

There were two firsts for the TREAT-NMD Education Team in the past few weeks; we held the first ever Education Masterclass for congenital myopathies (CM) in February and the first Duchenne muscular dystrophy (DMD) Early Diagnosis Seminar in March.  We are pleased to say that both events were a great success...

 
Read More
‌
‌
uncategorized-logo-cureduchenne

CureDuchenne Renews Support for TACT Academic Applicants

During travel restrictions over the past two years, the TREAT-NMD Advisory Committee for Therapeutics (TACT) has still managed to meet the needs of those seeking advice on their therapy development programmes for neuromuscular diseases...

 
Read More
‌
‌
Uncategorized Vancouver

TREAT-NMD 7th International Conference Programme Released

Full details of the programme for the 7th International TREAT-NMD Conference have now been released. The event features an exciting line up of expert speakers and opens with the session on Patient Engagement featuring speakers Nathan Peck, founder and CEO of Cure VCP Disease Inc and Terry Pirovolakis, founder of CureSPG50...

 
Read More
‌
‌
Uncategorized Conny Schneider XuTJZ7uD7PI Unsplash

Expanded Core Dataset Projects Update

We’re pleased to announce that the Swedish NMD Registry, Neuromuskulära sjukdomar i Sverige (NMD in Sweden) have recently completed their implementation of v1.2 of the Duchenne Muscular Dystrophy (DMD) dataset into their data collection platform...

 
Read More
‌
‌
uncategorized-dff-logo

Launch of the Daniel Ferguson Foundation

The Daniel Ferguson LGMD 2A foundation was launched on February 28th International Rare Disease Day...

 
Read More
‌
‌
Uncategorized JND New

Latest Edition of Journal of Neuromuscular Diseases Published

A new issue of Journal of Neuromuscular Diseases (JND) has been published online...

 
Read More
‌
‌
Uncategorized Treat NMD 25

FSHD Clinical Care Outcome Measures - A clinical Survey

This online survey will explore the range of outcome measures used in the clinical environment (ie. neuromuscular (MDA) clinics and rehabilitation facilities) to evaluate the functioning and quality of life of individuals with FSHD world-wide...

 
Read More
‌
‌
Uncategorized SMA Europe Primary RGB 01

SMA Europe's 11th Call For Research Proposals (2022) is Now Open

Principal Investigators and post-doctoral researchers are invited to submit proposals for research projects into spinal muscular atrophy (SMA)...

 
Read More
‌
‌
Uncategorized FSHD Europe

New Patient Pharma Study in FSHD

An important study has recently been announced between FSHD Europe and the John Walton Muscular Dystrophy Research Centre (JWMDRC) at Newcastle University...

 
Read More
‌
‌
Uncategorized Meeting Laughing

Upcoming Events

For information on upcoming conferences, events and rare disease days please visit the events section of our website. If you wish to notify us of an event that should be included in our listing, please complete the event form.

 
Read More
‌
Share this on Twitter
You have received this email because you have subscribed to TREAT-NMD as . If you no longer wish to receive emails please unsubscribe
webversion - unsubscribe - update profile
© 2023 TREAT-NMD, All rights reserved